Trial Search Results

A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal

The purpose of this study is to compare the efficacy of two commonly used medications in the treatment of alcohol withdrawal, diazepam and lorazepam.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Drug: Lorazepam
  • Drug: Diazepam

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Clinical diagnosis of alcohol withdrawal

   - History of alcohol use within 24 hours

   - Ability to consent to participate in the study

Exclusion Criteria:

   - Unwillingness to participate in the study

   - Active abuse of other CNS depressants

   - Acute intoxication with a CNS activating agent

   - Severe hepatic dysfunction

   - Pregnancy

   - History of dementia

Ages Eligible for Study

19 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting